Biotech PYC Therapeutics gets FDA orphan drug designation for vision-saving drug
Listed clinical-stage biotech PYC Therapeutics has received major backing from the US Food and Drug Administration for its drug treating a progressive and irreversible blinding eye disease. The Rohan Hockings-led company told the market on Friday it had …